08:00 WELCOME
Ursula Schmidt-Erfurth

08:15 - 09:00
SESSION I: The most important and educative cases of my entire career
Moderators: Lee Jampol, Anita Agarwal, William Mieler

• Challenging and educative cases from the experts are presented and discussed interactively among the panel
  Panellists: Mark Johnson, Jennifer Arnold

09:00 Coffee break

09:30 - 11:50
SESSION II: Artificial Intelligence in the management and understanding of retinal disease: Benefits and challenges
Moderators: Hrvoye Bogunovic, Ursula Schmidt-Erfurth

• Hrvoje Bogunovicn: Introduction: Where is AI in retina in 2023?
• Ramin Tadayoni: Fundus photography vs. OCT-A: The novel learnings
• Tunde Peto: Shared care: Current achievements and perspectives
• Gregor Reiter: AI-based fluid parameters in the management of neovascular AMD
• Robert Avery: The role and promise of AI in the universe of the private practice
  
  10:10 Discussion
   
• Daniela Ferrara: Revolutionizing clinical trials by AI
• Aaron Lee: The AI framework: Split or synchronized?
• Joel S. Schuman: OCT and AI: How did and will the two connect?
• Clarisa Sanchez: AI in retina: Which parameters and tools are fit for the clinic?
• Aaron Lee: A foundation model for generalizable discuse detection frame
  
  11:20 Discussion
  11:50 Lunch Break

12:50 - 14:30
SESSION III: Unmet needs in the management of retinal disease
Moderators: Andreas Pollreisz, Paul Sternberg

• Andreas Pollreisz: Introduction: The new diagnostic univers in diabetic retinopathy
• Jennifer Arnold: Sub-threshold laser to early AMD: Rationale, benefit and risk
• Catherine Cukras: Local and Global Associations of Reticular Pseudodrusen in AMD
• Paul Sternberg: Addressing the challenges in managing the unmet needs of patients with atrophic AMD
• Jordi Monés: How will we deal with GA from now on in clinical practice?
• Mark Johnson: Degenerative lamellar macular holes and other Muller gliopathies
• Matus Rehak: A state-of-the art in DME management in the real world: What we are missing
• Chang Ki Yoon: A comprehensive insight into Pseudodrusen and Function
  
  14:00 Discussion
  14:30 Break

15:00 -16:30
SESSION IV: The future is here to stay?
Moderators: Gregor Reiter, Sasha Fauser

• Ursula Schmidt-Erfurth: Introduction
• Michael Tolentino: Heralding the Glycomic Revolution
• Sascha Fauser: Treatment beyond intravitreal injection
• Guillaume Normand: Beyond FAF: The role of AI in the profiling and management of GA
• Reenie McCarthy: Beyond complement inhibition: Other targets to rescue photoreceptors
• Roy Schwartz: Pioneering the field in GA therapy
• Jacob Pichelmann: Developing AI for clinical decision support systems (CDSS)
  
  16:00 Discussion
  16:30 End

Fachärzte/-innen	Gebühren ab 250,00 EUR
Ärzte/-innen in Weiterbildung	Gebühren ab 150,00 EUR

Registration required. Please contact the organizer for further information.

Zertifizierung beantragt für CME Punkte bei der Ärztekammer Österreich